株式会社EXORPHIA
Tokyo, JP · 2 known investors
EXORPHIA develops extracellular vesicle (EV) technology for assisted reproductive medicine, focusing on cell-free IVF culture medium additives to improve embryo development and fertilization success rates. The company targets fertility clinics and academic institutions in reproductive medicine.
Founders & leadership
口幸
口石 幸治 (Kohji Kuchiishi)